<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2016-1-60-68</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-488</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW AND LECTURES</subject></subj-group></article-categories><title-group><article-title>АНАЛИЗ НАУЧНЫХ ИССЛЕДОВАНИЙ ПО ПРОДВИЖЕНИЮ ФАРМАЦЕВТИЧЕСКОЙ ПРОДУКЦИИ В ЗАРУБЕЖНЫХ СТРАНАХ: ПРАКТИЧЕСКИЕ РЕКОМЕНДАЦИИ ДЛЯ ФАРМАЦЕВТИЧЕСКИХ КОМПАНИЙ</article-title><trans-title-group xml:lang="en"><trans-title>ANALYSIS OF SCIENTIFIC RESEARCHES IN PHARMACEUTICAL PROMOTION GLOBALLY: TOWARDS INTERNATIONALLY DEVELOPING PRACTICALLY-ORIENTED GUIDELINES FOR PHARMACEUTICAL COMPANIES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бахлол</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bahlol</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>соискатель кафедры управления и экономики фармации медицинского факультета Российского университета дружбы народов</p></bio><bio xml:lang="en"><p>PhD, People’s Friendship University of Russia, Moscow, RussianFederation.</p></bio><email xlink:type="simple">Ph_hossni@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лагуткина</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lagutkina</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р фарм. наук, профессор кафедры управления и экономики фармации медицинского факультета Российского университета дружбы народов</p></bio><bio xml:lang="en"><p>doctor of pharmaceutical scinces, professor of the Department of management and economics of pharmacy, people’s Friendship University of Russia, Moscow, Russian Federation</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов, г. Москва 117198, ул. Миклухо-Маклая, д. 21, корпус 1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>People’s Friendship University of Russia, 117198, Moscow, St. Mikluho-Maklaja, h. 21</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>24</day><month>03</month><year>2016</year></pub-date><volume>15</volume><issue>1</issue><fpage>60</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бахлол М.М., Лагуткина Т.П., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Бахлол М.М., Лагуткина Т.П.</copyright-holder><copyright-holder xml:lang="en">Bahlol M.M., Lagutkina T.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/488">https://bulletin.ssmu.ru/jour/article/view/488</self-uri><abstract><sec><title>Цель</title><p>Цель. Фармацевтическая промышленность является важной отраслью для всех стран в мире. Многие фармацевтические компании осуществляют свою деятельность на международной арене. Разнообразные исследования в других странах подтвердили важность стимулирования сбыта в фармацевтической отрасли. Таким образом, стимулирование сбыта и его последствия – это очень важный вопрос, который необходимо глобально изучить в рамках теории и практики. Мы построили данное исследование исходя из его научной и практической ценности.</p></sec><sec><title>Методология исследования</title><p>Методология исследования. Мы изучили исследования, посвященные стимулированию сбыта в фармацевтической промышленности, из 25 разных стран мира, например, США, Канады, Италии, Франции, России, Индии, Египта и Сирии, где мы применяли наши знания трех наиболее распространенных в мире языков – английского, русского и арабского. На данных языках существует большое количество разнообразных научных работ, их знание дает возможность глубокого понимания и анализа данных. В некоторых исследованиях изучалось влияние продвижения на фармацевтический рынок, а в ряде работ – зависимость этого влияния от средств рекламы или характеристик лекарственного средства.</p></sec><sec><title>Новизна исследования</title><p>Новизна исследования. Мы исследовали эмпирические данные по стимулированию сбыта товаров в фармацевтической промышленности, которые могут быть направлены как потребителю, так и работникам в сфере здравоохранения.</p></sec><sec><title>Результаты исследования</title><p>Результаты исследования. Мы выделили, собрали и соотнесли информацию по продвижению фармацевтической продукции в мировом масштабе, что натолкнуло нас на некоторые выводы и практические результаты относительно средств продвижения в определенных ситуациях, имеющих отношение к основным направлениям; их эффекты по улучшению здоровья и благосостояния, а также побочные эффекты.</p></sec><sec><title>Практическая значимость</title><p>Практическая значимость. В результате мы разработали практико-ориентированные рекомендации для компаний касательно всемирного продвижения фармацевтической продукции, которые вы можете найти в конце данной статьи.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose. Pharmaceutical industry is transnational and globally important. Many pharmaceutical companies operate their business in multinational and international forms in different countries. Diverse researches from different countries indicated and confirmed marketing promotion importance in pharmaceutical field. Therefore, marketing promotion and its effects are a very important issue that should be globally investigated in real life and evidence context. We oriented our research according to these scientific and practical values.</p></sec><sec><title>Methodology</title><p>Methodology. We reviewed pharmaceutical marketing promotion researches from more than 25 different countries, e.g., USA, Canada, Italy, France, Russia, India, Egypt and Syria where we employed our knowledge of three widely spread languages, i.e., English, Russian and Arabic. Such language variation supports us with large and variable amount of scientific knowledge, deep understanding and ability of analysis. Some studies investigated average response to pharmaceutical marketing promotion and few studies took into consideration heterogeneity in their effects with respect to advertising medium or drug characteristics.</p></sec><sec><title>Originality</title><p>Originality. We investigated empirical evidences of pharmaceutical marketing promotion that can be directed to either consumer or healthcare professionals.</p></sec><sec><title>Findings</title><p>Findings. We extracted, gathered and associated information of pharmaceutical promotion globally which oriented us to several evidence and practical facts with regard to employing promotion tools in different definite situations pertinent to main directions; their welfare and health enhancing effects and adverse effects. Practical Implications- Consequently, we developed practically-oriented guidelines for companies concerning pharmaceutical promotion globally ate the end of this paper.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фармацевтическая промышленность</kwd><kwd>стимулирование сбыта</kwd><kwd>в мировом масштабе</kwd><kwd>эмпирические данные</kwd><kwd>потребитель</kwd><kwd>работники в сфере здравоохранения</kwd><kwd>практико-ориентированные рекомендации.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pharmaceutical industry</kwd><kwd>marketing promotion</kwd><kwd>globally</kwd><kwd>empirical evidences</kwd><kwd>consumer</kwd><kwd>healthcare professionals</kwd><kwd>practically-oriented guidelines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Saba’ S. The Relation Between simple Marketing And Success Of Products Developments, Master degree, faculty of commerce, Mansoura University, Egypt. 2012.</mixed-citation><mixed-citation xml:lang="en">Saba’ S. The Relation Between simple Marketing And Success Of Products Developments, Master degree, faculty of commerce, Mansoura University, Egypt. 2012.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bahlol Mohammed Mostafa, L.T.P. Survey on using pharmaceutical promotion in Egypt. The USA Journal of Applied Sciences, December 2015. 6: p. 3–5.</mixed-citation><mixed-citation xml:lang="en">Bahlol Mohammed Mostafa, L.T.P. Survey on using pharmaceutical promotion in Egypt. The USA Journal of Applied Sciences, December 2015. 6: p. 3–5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shalash Anbar, A.h.S.a. A.M. The Effect of Using Electronic Marketing to Achieving Competitive Advantage for Jordanian Pharmaceutical companies. Journal of managerial sciences studying. Jordanian University, 2011. 38 (1).</mixed-citation><mixed-citation xml:lang="en">Shalash Anbar, A.h.S.a. A.M. The Effect of Using Electronic Marketing to Achieving Competitive Advantage for Jordanian Pharmaceutical companies. Journal of managerial sciences studying. Jordanian University, 2011. 38 (1).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammed Abidat, H.A.G. The Effect Of Marketing Mix in Preferring Of Jordanian Pharmacists Of Local Drugs Over Foreign Drugs. Journal of managerial sciences studying. Jordanian University, 2011. 38 (1).</mixed-citation><mixed-citation xml:lang="en">Mohammed Abidat, H.A.G. The Effect Of Marketing Mix in Preferring Of Jordanian Pharmacists Of Local Drugs Over Foreign Drugs. Journal of managerial sciences studying. Jordanian University, 2011. 38 (1).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Linda D. Pharmaceutical Marketing (Case Study of Sidal organization). Philosophy of doctorate degree, economical Science Faculty, Dali Ibrahim University. Algeria, 2010.</mixed-citation><mixed-citation xml:lang="en">Linda D. Pharmaceutical Marketing (Case Study of Sidal organization). Philosophy of doctorate degree, economical Science Faculty, Dali Ibrahim University. Algeria, 2010.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bolsheva S.N. Research of organizational aspects of drug promotion in the Russian pharmaceutical market, in pharmaceutical management and economy. M.: People’s Friendship University of Russia. 2002.</mixed-citation><mixed-citation xml:lang="en">Bolsheva S.N. Research of organizational aspects of drug promotion in the Russian pharmaceutical market, in pharmaceutical management and economy. M.: People’s Friendship University of Russia. 2002.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bhattacharya J. and Vogt W.B. A Simple Model of Pharmaceutical Price Dynamics // Journal of Law and Economics. 2003. 46 (2): p. 599–626.</mixed-citation><mixed-citation xml:lang="en">Bhattacharya J. and Vogt W.B. A Simple Model of Pharmaceutical Price Dynamics // Journal of Law and Economics. 2003. 46 (2): p. 599–626.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dave D. and Saffer H. Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand. Southern Economic Journal, 2012. 79(1): p. 97–126.</mixed-citation><mixed-citation xml:lang="en">Dave D. and Saffer H. Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand. Southern Economic Journal, 2012. 79(1): p. 97–126.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lagutkina T. and Bahlol M., Izuchenie organizacionnyh aspektov prodvizhenija na farmacevticheskom rynke EGIPTA. Mezhdunarodnyj nauchno- issledovatel’skij zhurnal, 2015 (4–3 (35)).</mixed-citation><mixed-citation xml:lang="en">Lagutkina T. and Bahlol M., Izuchenie organizacionnyh aspektov prodvizhenija na farmacevticheskom rynke EGIPTA. Mezhdunarodnyj nauchno- issledovatel’skij zhurnal, 2015 (4–3 (35)).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Khateib R.A. The Effect Of Direct Consumer Advertising On The Purchasing Decisions, Master Degree Of Business Administration, University of Middle East, Jordan. 2012.</mixed-citation><mixed-citation xml:lang="en">Khateib R.A. The Effect Of Direct Consumer Advertising On The Purchasing Decisions, Master Degree Of Business Administration, University of Middle East, Jordan. 2012.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wosinska M. Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products. Direct-to-Consumer advertising and the demand for pharmaceutical products (October 2002). HBS Marketing Research Paper, 2002 (02–04).</mixed-citation><mixed-citation xml:lang="en">Wosinska M. Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products. Direct-to-Consumer advertising and the demand for pharmaceutical products (October 2002). HBS Marketing Research Paper, 2002 (02–04).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Iizuka T. and Jin G.Z. The effect of prescription drug advertising on doctor visits. Journal of Economics &amp; Management Strategy, 2005. 14(3): p. 701–727.</mixed-citation><mixed-citation xml:lang="en">Iizuka T. and Jin G.Z. The effect of prescription drug advertising on doctor visits. Journal of Economics &amp; Management Strategy, 2005. 14(3): p. 701–727.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q. and Gupta S. The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: empirical findings and public policy impli- cations. International Journal of research in Marketing, 2011. 28(3): p. 205–217.</mixed-citation><mixed-citation xml:lang="en">Liu Q. and Gupta S. The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: empirical findings and public policy impli- cations. International Journal of research in Marketing, 2011. 28(3): p. 205–217.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Meyerhoefer C.D. and Zuvekas S.H., The shape of demand: What does it tell us about direct-to-consumer marketing of antidepressants? The BE Journal of Economic Analysis &amp; Policy, 2008. 8 (2).</mixed-citation><mixed-citation xml:lang="en">Meyerhoefer C.D. and Zuvekas S.H., The shape of demand: What does it tell us about direct-to-consumer marketing of antidepressants? The BE Journal of Economic Analysis &amp; Policy, 2008. 8 (2).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Donohue J.M., Cevasco M. and Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 2007. 357 (7): p. 673–681.</mixed-citation><mixed-citation xml:lang="en">Donohue J.M., Cevasco M. and Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 2007. 357 (7): p. 673–681.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Richards-Shubik, S., David G., and Markowitz S. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. American Economic Journal: Economic Policy. 2: p. 1–25.</mixed-citation><mixed-citation xml:lang="en">Richards-Shubik, S., David G., and Markowitz S. The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. American Economic Journal: Economic Policy. 2: p. 1–25.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bradford W.D. et al. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians’ prescribing behavior. Health Affairs, 2006. 25(5): p. 1371–1377.</mixed-citation><mixed-citation xml:lang="en">Bradford W.D. et al. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians’ prescribing behavior. Health Affairs, 2006. 25(5): p. 1371–1377.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kalyanaram G. and Subramaniam B. The Effect of Direct Advertising to Consumers (DTCA) In Prescription Pharmaceutical Drugs, and Consumer Welfare. Proceedings of the Northeast Business &amp; Economics Association, 2010.</mixed-citation><mixed-citation xml:lang="en">Kalyanaram G. and Subramaniam B. The Effect of Direct Advertising to Consumers (DTCA) In Prescription Pharmaceutical Drugs, and Consumer Welfare. Proceedings of the Northeast Business &amp; Economics Association, 2010.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkes M.S., Bell R.A. and Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 2000. 19 (2): p. 110–128.</mixed-citation><mixed-citation xml:lang="en">Wilkes M.S., Bell R.A. and Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 2000. 19 (2): p. 110–128.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Calfee J.E., Winston C. and Stempski R. Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs*. Journal of Law and Economics, 2002. 45(S2): p. 673–690.</mixed-citation><mixed-citation xml:lang="en">Calfee J.E., Winston C. and Stempski R. Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs*. Journal of Law and Economics, 2002. 45(S2): p. 673–690.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bradford W.D. et al. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clinical Therapeutics, 2006. 28(12): p. 2105–2118.</mixed-citation><mixed-citation xml:lang="en">Bradford W.D. et al. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clinical Therapeutics, 2006. 28(12): p. 2105–2118.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Donohue J.M. et al. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical care, 2004. 42(12): p. 1176–1185.</mixed-citation><mixed-citation xml:lang="en">Donohue J.M. et al. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical care, 2004. 42(12): p. 1176–1185.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Toop L. and Mangin D. Industry funded patient information and the slippery slope to New Zealand. BMJ, 2007. 335 (7622): p. 694–695.</mixed-citation><mixed-citation xml:lang="en">Toop L. and Mangin D. Industry funded patient information and the slippery slope to New Zealand. BMJ, 2007. 335 (7622): p. 694–695.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Toop L. et al. Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit. Report to the Minister of Health supporting the case for a ban on DTCA. Dunedin: University of Otago, 2003: p. 2.</mixed-citation><mixed-citation xml:lang="en">Toop L. et al. Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit. Report to the Minister of Health supporting the case for a ban on DTCA. Dunedin: University of Otago, 2003: p. 2.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Law M.R., Majumdar S.R. and Soumerai S.B. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ, 2008. 337.</mixed-citation><mixed-citation xml:lang="en">Law M.R., Majumdar S.R. and Soumerai S.B. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ, 2008. 337.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen. Survey: canadian retailers will drop prices to retain customers. 2014; Available from: http://www.marketingmag.ca/consumer/survey-canadian-retailers-will-drop-prices-to-retain-customers-113302.</mixed-citation><mixed-citation xml:lang="en">Nielsen. Survey: canadian retailers will drop prices to retain customers. 2014; Available from: http://www.marketingmag.ca/consumer/survey-canadian-retailers-will-drop-prices-to-retain-customers-113302.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Тer-Gazarjan A.G. Development of strategy of regulation of relationship of the pharmaceutical organizations with target audiences, in management and economics of pharmacy. 2007, Peoples’ Friendship University of Russia: Moscow.</mixed-citation><mixed-citation xml:lang="en">Тer-Gazarjan A.G. Development of strategy of regulation of relationship of the pharmaceutical organizations with target audiences, in management and economics of pharmacy. 2007, Peoples’ Friendship University of Russia: Moscow.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Herxheimer A., Lundborg C.S. and Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. International Journal of Health Services, 1993. 23(1): p. 161–172.</mixed-citation><mixed-citation xml:lang="en">Herxheimer A., Lundborg C.S. and Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. International Journal of Health Services, 1993. 23(1): p. 161–172.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Vlassov V. et al. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? Western Journal of Medicine, 2001. 174(6): p. 391.</mixed-citation><mixed-citation xml:lang="en">Vlassov V. et al. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? Western Journal of Medicine, 2001. 174(6): p. 391.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pharmaceutical detailing definition. 2015.</mixed-citation><mixed-citation xml:lang="en">Pharmaceutical detailing definition. 2015.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Abbas A. et al. Evaluation of Knowledge of Pharmacist and Non Pharmacist Medical Sales Representatives (MSRs) in Pharmaceutical Drug Promotion: A Comparative Study. Advanced Biomedical Bulletin, 2014. 2(1): p. 40–48.</mixed-citation><mixed-citation xml:lang="en">Abbas A. et al. Evaluation of Knowledge of Pharmacist and Non Pharmacist Medical Sales Representatives (MSRs) in Pharmaceutical Drug Promotion: A Comparative Study. Advanced Biomedical Bulletin, 2014. 2(1): p. 40–48.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chintagunta P.K. and Desiraju R. Strategic pricing and detailing behavior in international markets. Marketing Science, 2005. 24(1): p. 67–80.</mixed-citation><mixed-citation xml:lang="en">Chintagunta P.K. and Desiraju R. Strategic pricing and detailing behavior in international markets. Marketing Science, 2005. 24(1): p. 67–80.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Berndt E.R., Danzon P.M. and Kruse G.B. Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion. Managerial and Decision Economics, 2007. 28(4-5): p. 231–250.</mixed-citation><mixed-citation xml:lang="en">Berndt E.R., Danzon P.M. and Kruse G.B. Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion. Managerial and Decision Economics, 2007. 28(4-5): p. 231–250.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gowad M.A.E. Evaluation of Satisfaction level Of Customers To Pharmaceutical Sales Men Performance iIn The Market Of Gaza Sector, Islamic University, Gaza. 2007.</mixed-citation><mixed-citation xml:lang="en">Gowad M.A.E. Evaluation of Satisfaction level Of Customers To Pharmaceutical Sales Men Performance iIn The Market Of Gaza Sector, Islamic University, Gaza. 2007.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Taking the Pulse® Pharmacists 2012, Pharmacist Market Trends, L. Manhattan Research, Editor. 2012.</mixed-citation><mixed-citation xml:lang="en">Taking the Pulse® Pharmacists 2012, Pharmacist Market Trends, L. Manhattan Research, Editor. 2012.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Hurwitz M.A. and Caves R.E. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. Journal of Law and Economics, 1988: p. 299-320.</mixed-citation><mixed-citation xml:lang="en">Hurwitz M.A. and Caves R.E. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. Journal of Law and Economics, 1988: p. 299-320.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Morton F.M.S. Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. International Journal of Industrial Organization, 2000. 18(7): p. 1085–1104.</mixed-citation><mixed-citation xml:lang="en">Morton F.M.S. Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. International Journal of Industrial Organization, 2000. 18(7): p. 1085–1104.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Leffler K.B. Persuasion or information-the economics of prescription drug advertising. JL &amp; Econ., 1981. 24: p. 45.</mixed-citation><mixed-citation xml:lang="en">Leffler K.B. Persuasion or information-the economics of prescription drug advertising. JL &amp; Econ., 1981. 24: p. 45.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Irvine C. Healthcare Data Solutions Announces Results of Physician Survey “Marketing That Makes Physicians Respond: What They Told Us”. 2013.</mixed-citation><mixed-citation xml:lang="en">Irvine C. Healthcare Data Solutions Announces Results of Physician Survey “Marketing That Makes Physicians Respond: What They Told Us”. 2013.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Narendran R. and Narendranathan M. Influence of pharmaceutical marketing on prescription practices of physicians. 2013.</mixed-citation><mixed-citation xml:lang="en">Narendran R. and Narendranathan M. Influence of pharmaceutical marketing on prescription practices of physicians. 2013.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Zaki N.M. Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study. Saudi Pharmaceutical Journal, 2014. 22(6): p. 528-536.</mixed-citation><mixed-citation xml:lang="en">Zaki N.M. Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study. Saudi Pharmaceutical Journal, 2014. 22(6): p. 528-536.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenthal M.B. et al. Demand effects of recent changes in prescription drug promotion. in Forum for Health Economics &amp; Policy. 2003.</mixed-citation><mixed-citation xml:lang="en">Rosenthal M.B. et al. Demand effects of recent changes in prescription drug promotion. in Forum for Health Economics &amp; Policy. 2003.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Berndt E.R. et al. Information, marketing, and pricing in the US antiulcer drug market. The American Economic Review, 1995: p. 100-105.</mixed-citation><mixed-citation xml:lang="en">Berndt E.R. et al. Information, marketing, and pricing in the US antiulcer drug market. The American Economic Review, 1995: p. 100-105.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Jin G.Z. and Iizuka T. Direct to Consumer Advertising and Prescription Choice. Journal of Industrial Economics, 2007.</mixed-citation><mixed-citation xml:lang="en">Jin G.Z. and Iizuka T. Direct to Consumer Advertising and Prescription Choice. Journal of Industrial Economics, 2007.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kwong W.J. and Norton E.C. The effect of advertising on pharmaceutical innovation. Review of Industrial Organization,2007. 31(3): p. 221-236.</mixed-citation><mixed-citation xml:lang="en">Kwong W.J. and Norton E.C. The effect of advertising on pharmaceutical innovation. Review of Industrial Organization,2007. 31(3): p. 221-236.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Narayanan S., Desiraju R., and Chintagunta P.K., Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of marketing, 2004. 68(4): p. 90–105.</mixed-citation><mixed-citation xml:lang="en">Narayanan S., Desiraju R., and Chintagunta P.K., Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of marketing, 2004. 68(4): p. 90–105.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Narayanan S., Manchanda P. and Chintagunta P.K., Temporal differences in the role of marketing communication in new product categories. Journal of Marketing Research, 2005. 42(3): p. 278–290.</mixed-citation><mixed-citation xml:lang="en">Narayanan S., Manchanda P. and Chintagunta P.K., Temporal differences in the role of marketing communication in new product categories. Journal of Marketing Research, 2005. 42(3): p. 278–290.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
